Anahita Bassir Nia
LightNews LightNews
anahitabn.bsky.social
Anahita Bassir Nia
@anahitabn.bsky.social
100 followers 38 following 10 posts
Addiction Psychiatrist
Assistant Professor of Psychiatry @Yale
I study the neurobiology of addiction and ptsd. My focus is cannabinoids and psychedelics.
I love hiking, skiing, reading, traveling, and working!
Posts Replies Media Videos
Reposted by Anahita Bassir Nia
abnlab.bsky.social
Read our latest #research on the contribution of #CBD in treatment for #opioid #addiction, published with @WileyGlobal in Addiction Biology on behalf of The Society for the Study of Addiction. Read here: doi.org/10.1111/adb.....
The Potential Use of Cannabidiol in the Treatment of Opioid Use Disorder: A Systematic Review
This systematic review found that CBD may reduce opioid cravings and abstinence-related anxiety in individuals with opioid use disorder. Preclinical studies also suggest CBD can reduce withdrawal sym...
doi.org
May 29, 2025 at 4:05 PM
anahitabn.bsky.social
Lost my voice almost all the #SOBP! Could not present for my #early-career panel and my poster! #worst #SOBP2025 ever!
April 26, 2025 at 10:49 PM
anahitabn.bsky.social
Interested in #endocannabinoid system in #opioid use disorder? Let's talk.
#SOBP2025
abnlab.bsky.social abnlab.bsky.social @abnlab.bsky.social · Apr 23
Yale ABNLab will be presenting at SOBP 2025 in Toronto this week! Please see below for more details! #Neuroscience #NeuroPsych #PsychResearch #2025SOBP
April 23, 2025 at 11:29 PM
anahitabn.bsky.social
Very interesting paper published by @alexkwan.bsky.social @nature.com on the cell types and receptors involved in #psilocybin induced enhanced #neuroplasticity and #stress ameliorating #behavioral effects.
alexkwan.bsky.social Alex Kwan @alexkwan.bsky.social · Apr 2
Our latest study identifies a specific cell type and receptor essential for psilocybin’s long-lasting neural and behavioral effects 🍄🔬🧠🧪

Led by Ling-Xiao Shao and @ItsClaraLiao

Funded by @NIH @NIMHgov

📄 Read in @nature.com - www.nature.com/articles/s41...

1/12
Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors - Nature
A pyramidal cell type and the 5-HT2A receptor in the medial frontal cortex have essential roles in psilocybin’s long-term drug action.
www.nature.com
April 2, 2025 at 9:08 PM
anahitabn.bsky.social
The latest paper from my lab.

Is #psychotherapy necessary for the therapeutic effects of #psychedelics?
February 22, 2025 at 2:52 AM
Reposted by Anahita Bassir Nia
harpaz-rotem.bsky.social
A wonderful work from Nachshon Korem who explored the paradox of emotional numbing and hypervigilance in PTSD
jamanetwork.com/journals/jam...
Emotional State Transitions in Trauma-Exposed Individuals With and Without PTSD
This cross-sectional study examines whether trauma-exposed individuals with posttraumatic stress disorder have a sharper transition between neutral and negative emotional states compared with trauma-e...
jamanetwork.com
December 25, 2024 at 3:32 PM
anahitabn.bsky.social
Another poster from @abnlab.bsky.social with @harpaz-rotem.bsky.social on #cannabinoid receptor type 1 availability in #ptsd with #childhood_trauma today at 5pm.
#acnp2024
@acnporg.bsky.social
December 10, 2024 at 3:04 PM
anahitabn.bsky.social
A pre #acnp2024 #hike in #Sedona. I hiked #cathedralrock, #littlehorse, and #chapeltrail. I had underestimated #arizona sun! But the trails were wonderful!
@acnporg.bsky.social
@abnlab.bsky.social
December 8, 2024 at 12:45 AM
anahitabn.bsky.social
Heading to #acnp2024 to present my research on the #endocannabinoid system in #opioid use disorder.

@abnlab.bsky.social
@acnporg.bsky.social
#acnp2024
abnlab.bsky.social abnlab.bsky.social @abnlab.bsky.social · Dec 6
ABN Lab's Dr. Anahita Bassir Nia will be presenting the results of her NIDA-funded study on CB1R availability in opioid use disorder this upcoming Monday, December 9th at #ACNP2024!
December 7, 2024 at 1:00 AM